Zomedica pharmaceuticals corp. (ZOM)

CashFlow / TTM
Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17
Cash flows used in operating activities:
Net loss

-19,784

-25,348

-24,413

-26,153

-16,647

-10,789

-10,959

-8,403

-8,065

0

0

0

Adjustments for
Depreciation

277

254

270

229

203

173

110

106

89

0

0

0

Amortization - intangible assets

1

1

1

1

2

2

2

2

2

0

0

0

Amortization - right-of-use asset

509

0

0

0

-

-

-

-

-

-

-

-

Loss on fixed asets

-

-

0

-

-

-

-

-

-

-

-

-

Loss on sale of equipment

-

-

-

-

-

0

-

-

-

0

-

-

Stock issued for services

792

792

2,030

0

-

1,468

0

-

275

0

0

0

Stock-based compensation

2,539

2,539

2,341

2,342

7

19

695

693

849

0

0

0

Change in non-cash operating working capital
Trade and other receivable

13

38

45

8

25

8

33

46

9

0

0

0

Prepaid expenses

-239

-207

-386

-52

124

381

392

173

205

0

0

0

Deposits

-92

462

1,765

1,498

1,832

1,255

-60

-122

124

0

0

0

Accounts payable and accrued liabilities

-288

-862

113

6,507

1,547

897

1,172

221

94

0

0

0

-15,634

-18,255

-17,716

-12,021

-11,147

-9,803

-7,875

-7,247

-7,093

0

0

0

Cash flows from financing activities:
Cash proceeds from issuance of preferred shares

-

-

0

-

-

-

-

-

-

-

-

-

Cash proceeds from issuance of common shares

3,000

3,000

7,002

0

-

4,002

0

-

6,570

0

0

0

Cash received from stock option exercises

600

1,097

1,195

1,226

2,034

2,416

2,378

2,370

979

0

0

0

Cash paid on stock issuance costs

708

640

662

0

-

39

0

-

56

0

0

0

Repayments of shareholder loan

-

-

-

-

-

0

-

-

-6

0

0

0

14,891

19,727

19,815

11,857

10,258

6,379

9,654

8,642

7,486

0

0

0

Cash flows used in investing activities:
Investment in intangibles

-

0

-

-

-

-

-

-

-

-

-

-

Investment in property and equipment

155

178

564

683

627

612

149

27

171

0

0

0

-686

-670

-555

-674

-618

-612

-149

-27

-171

0

0

0

Decrease in cash and cash equivalents

-1,429

801

1,542

-838

-1,507

-4,036

1,629

1,367

221

0

0

0

Supplemental cash flow information:
Interest Paid

18

0

0

0

-

-

-

-

-

-

-

-